Vascular Bioengineering Research / Vasometabolic Bioengineering Group (VBG)

Vasometabolic bioengineering research explores the intricate connections between the vascular system and metabolic processes. This dynamic field combines bioengineering principles with cutting-edge technologies to advance the prevention and management of significant diseases such as carotid artery disease, aneurysms, peripheral arterial disease, diabetes, and relevant risk factors. By merging engineering expertise with clinical insights, professionals are collaborating to develop innovative solutions to these complex medical challenges by shifting the focus from pathology to the target tissues. Through translational research and clinical studies, our goal is to bridge the gap between laboratory discoveries and real-world applications. This involves translating fundamental research findings into biomarker discovery, diagnostic tools, and prevention strategies for health issues linked to the vascular system and its interaction with the tissue metabolic environment.

Key research areas in vasometabolic bioengineering: 
 

-   Vascular and soft tissue biomechanics

-   Innovative non-invasive imaging and sensing techniques 

-   Computational modeling of tissue physiology and disease pathophysiology 

-   3D Bioprinting 

-   Vasometabolic biomarker discovery and monitoring 

-   Multi-omics approaches 

-   Advanced data processing and AI-based techniques 

-   Robot-assisted solutions